Belite Bio, Inc
(BLTE)Financial Statements · SEC EDGAR XBRL
Net Income
-$77.6M
-114.7%
EPS
$-2.31
-95.8%
Op. Income
-$84.2M
-110.5%
FCF
-$37.1M
-26.3%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Selling General & Admin
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)